News Roundup: February 21 to February 25

Your weekly roundup of the latest news from Drug Topics®.

Drug Delivery: The Sky is Not the Limit

The use of drones to deliver critically important therapies can help overcome the barriers to care that impact patients in metropolitan areas.

Read more

AbbVie Submits Supplemental NDA for Vraylar for Adjunctive MDD Therapy

Cariprazine is already approved to treat schizophrenia and bipolar I in adults.

Read more

This Week in COVID-19: As New Omicron Variant Circulates, States Lift Mask Mandates

COVID-19 updates and news to know as of February 21, 2022.

Read more

Cancer and COVID-19: Solving the Puzzle of Vaccination

Recent treatment may affect the antibody response, particularly among those with hematologic cancers.

Read more

Efficacy Outcomes of Some Cancer Biosimilars Indistinguishable Vs Reference Product

Findings from a systematic review found little difference in outcomes between biosimilar and reference product treatment options.

Read more